Anti-allergic effects of a nonameric peptide isolated from the intestine gastrointestinal digests of abalone (Haliotis discus hannai) in activated HMC-1 human mast cells

Int J Mol Med. 2016 Jan;37(1):243-50. doi: 10.3892/ijmm.2015.2420. Epub 2015 Nov 27.

Abstract

The aim of the present study was to examine whether the intestine gastrointestinal (GI) digests of abalone [Haliotis discus hannai (H. discus hannai)] modulate inflammatory responses and to elucidate the mechanisms involved. The GI digests of the abalone intestines were fractionated into fractions I (>10 kDa), II (5-10 kDa) and Ⅲ (<5 kDa). Of the abalone intestine GI digests (AIGIDs), fraction Ⅲ inhibited the passive cutaneous anaphylaxis (PCA) reaction in mice. Subsequently, a bioactive peptide [abalone intestine GI digest peptide (AIGIDP)] isolated from fraction Ⅲ was determined to be 1175.2 Da, and the amino acid sequence was found to be PFNQGTFAS. We noted that the purified nonameric peptide (AIGIDP) attenuated the phorbol‑12‑myristate 13-acetate plus calcium ionophore A23187 (PMACI)-induced histamine release and the production of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin (IL)-1β and IL-6 in human mast cells (HMC-1 cells). In addition, we also noted that AIGIDP inhibited the PMACI‑induced activation of nuclear factor‑κB (NF-κB) by suppressing IκBα phosphorylation and that it suppressed the production of cytokines by decreasing the phosphorylation of JNK. The findings of our study indicate that AIGIDP exerts a modulatory, anti-allergic effect on mast cell-mediated inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Allergic Agents / isolation & purification
  • Anti-Allergic Agents / pharmacology*
  • Biological Products / isolation & purification
  • Biological Products / pharmacology*
  • Cell Line
  • Cell Survival / drug effects
  • Cytokines / immunology
  • Gastrointestinal Tract / chemistry
  • Gastropoda / chemistry*
  • Histamine Release / drug effects*
  • Humans
  • Immunoglobulin E / immunology
  • Inflammation Mediators / immunology
  • Male
  • Mast Cells / cytology
  • Mast Cells / drug effects*
  • Mast Cells / immunology
  • Mice, Inbred ICR
  • Mitogen-Activated Protein Kinases / immunology
  • NF-kappa B / immunology
  • Passive Cutaneous Anaphylaxis / drug effects
  • Peptides / isolation & purification
  • Peptides / pharmacology*

Substances

  • Anti-Allergic Agents
  • Biological Products
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • Peptides
  • Immunoglobulin E
  • Mitogen-Activated Protein Kinases